Charles River Labs (CRL) PT Lowered to $220 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $326.29 --0%
Rating Summary:
24 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
24 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant lowered the price target on Charles River Labs (NYSE: CRL) to $220.00 (from $225.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Charles River Labs (CRL) PT Raised to $387 at UBS
- GXO Logistics Inc. (GXO) PT Raised to $69 at UBS
- Sprout Social Inc. (SPT) PT Raised to $13 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
